Description

CJC-1275 with DAC – Research Peptide

CJC-1275 with DAC is a synthetic peptide compound widely utilized in laboratory and scientific research settings focused on growth hormone–related signaling pathways. The addition of DAC (Drug Affinity Complex) is designed to extend the peptide’s biological half-life, making it of particular interest for long-acting peptide research applications.

This compound is structurally engineered to interact with growth hormone–releasing hormone (GHRH) receptors in controlled research environments. Due to its prolonged activity profile, CJC-1275 with DAC is frequently studied for its potential role in sustained peptide signaling dynamics over extended observation periods.

Key Research Characteristics

• Synthetic peptide combined with Drug Affinity Complex (DAC)

• Designed for extended stability and longevity in research models

• Commonly referenced in growth hormone pathway research

• Supplied in lyophilized (freeze-dried) form for laboratory handling

• Intended strictly for in-vitro or laboratory research use

Important Notice

This product is sold for research purposes only. It is not intended for human or animal consumption, medical use, diagnostic use, or therapeutic application. No claims are made regarding safety, efficacy, or outcomes. The purchaser assumes all responsibility for proper handling, storage, and use in compliance with applicable laws and regulations.

By purchasing this product, the buyer acknowledges that it is intended solely for legitimate research purposes conducted by qualified individuals.